Image

Clinical-MRI Evaluation in Patients Undergoing Subtalar Arthrorisis With Reabsorbable Endorthesis Implant in PLLA

Recruiting
8 - 15 years of age
Both
Phase N/A

Powered by AI

Overview

From the archives of the IRCCS Rizzoli Orthopedic Institute, all cases of arthrorrhesis of the subtalar joint with a reabsorbable endorthotic implant in PLLA will be retrieved. An overall electronic database will be created and all medical records of these cases will be reviewed.

The eligibility of each individual patient will be assessed on the basis of the exclusion and inclusion criteria (non-probability convenience sampling).

The study will not present a control group or comparison groups between therapeutic procedures.

Eligibility

Inclusion Criteria:

  • Age between 8 and 15 years at the time of surgery
  • Arthrorrhosis of the subtalar with reabsorbable endorthotic implant in PLLA
  • Minimum follow-up of 5 years

Exclusion Criteria:

  • Revisions/explantation of the endorthesis device
  • Patients with active acute or chronic infections
  • Patients with chronic inflammatory joint diseases
  • Patients with previous significant trauma of the lower limbs following surgery
  • Patients with pre-existing anomalies of ambulatory kinematics (amputations, neuro-muscular diseases, poliomyelitis, hip dysplasias)
  • Patients with cognitive deficits

-

  • Patients with concomitant neurological pathologies
    • Patients suffering from tumor pathology
    • Patients with cardiac pacemakers or other prostheses equipped with electronic circuits
    • Patients with intracranial metal implants, metal heart valves, vascular clips, ferromagnetic endovascular filters/stents/coils, Swan-Ganz catheters or in any case positioned close to vital anatomical structures
    • Patients with orthopedic metal prostheses
    • Patients with cochlear implants or fixed hearing aids, lens prostheses with ferromagnetic intra-ocular points, IUD (coil) or splinters made of ferromagnetic material
    • Pregnant patients
    • Patients with insulin pumps and non-removable contact lenses

Study details

Lower Limb Deformity

NCT06525532

Istituto Ortopedico Rizzoli

30 January 2025

Step 1 Get in touch with the nearest study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.